Table I.
Clinical and Demographic Characteristics: Bivariate Analysis
| Variable | Control (n=20) | Gout (n=20) | P Value |
|---|---|---|---|
| Age, y | 41.7±10.5 | 47.6±11 | .19 |
| Sex, No. (%) | 17 (85) | 19 (95) | .6 |
| BMI | 30.1±4.2 | 33.6±6.5 | .054 |
| SBP, mm Hg | 140.7±11.2 | 138.6±18.4 | .84 |
| DBP, mm Hg | 82.2±10.4 | 83.6±9.7 | .52 |
| Total cholesterol, mg/dL | 187.6±32.0 | 200±27.4 | .39 |
| Triglycerides, mg/dL | 97.9±39.5 | 201.3±153.0 | .001 |
| HDL, mg/dL | 50.7±10.5 | 43.1±8.7 | .02 |
| LDL, mg/dL | 116±26.8 | 122.0±24.5 | .73 |
| Serum uric acid, mg/dL | 6.1±1.4 | 8.9±1.4 | <.0001 |
| Urine uric acid, 24‐h | 460±204.1 | 727.0±271.6 | .004 |
| BUN, mg/dL | 14.9±3.6 | 16.2±3.2 | .27 |
| Creatinine, mg/dL | 0.9±0.1 | 1.2±0.9 | .14 |
| Fasting glucose, mg/dL | 91.4±10.9 | 91.3±10.0 | .83 |
| Framingham risk score | 2.2±3.8 | 4.3±2.1 | .053 |
Values are expressed as mean ± standard deviation unless otherwise indicated. Abbreviations: BMI, body mass index; BUN, serum urea nitrogen; DBP, diastolic blood pressure; HDL, high‐density lipoprotein cholesterol; LDL, low‐density lipoprotein cholesterol; SBP, systolic blood pressure.